|
|
||||||||
J Thorac Cardiovasc Surg 2007;133:397-403
© 2007 The American Association for Thoracic Surgery
Surgery for Acquired Cardiovascular Disease |
a Department of Internal Medicine E, Rabin Medical Center, Beilinson Hospital and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
b Infection Control Unit, Rabin Medical Center, Beilinson Hospital, Tel-Aviv, Israel
c Department of Anesthesia, Rabin Medical Center, Beilinson Hospital, Tel-Aviv, Israel.
Received for publication July 30, 2006; revisions received September 30, 2006; accepted for publication October 9, 2006. * Address for reprints: Mical Paul, MD, Internal Medicine E and Infectious Diseases Unit, Rabin Medical Center, Beilinson Hospital, Petah Tikva, 49100, Israel. (Email: pil1pel{at}zahav.net.il).
OBJECTIVE: Prediction of surgical site infection and mortality after cardiac surgery might allow for interventions to reduce adverse outcomes. We sought to evaluate existing risk scores.
METHODS: We included 809 consecutive patients undergoing coronary artery bypass surgery. Data were collected prospectively. Infections were defined as deep sternal wound infection or mediastinitis by using established criteria and evaluated 60 days after surgical intervention. All-cause mortality was assessed at 30 days and 6 months. We assessed the ability of the National Nosocomial Infections Surveillance risk index, the EuroSCORE, and the Society of Thoracic Surgeons risk score to predict infection and mortality. Discrimination was assessed using the area under the receiver operating curve.
RESULTS: The rate of surgical site infection was 3.6% (29/809 patients). The National Nosocomial Infections Surveillance risk index showed moderate discrimination for infection (area under the receiver operating curve of 0.64) and poor ability to stratify patients into infection risk groups. The EuroSCORE predicted infection and 30-day and 6-month mortality with good discrimination (area under the receiver operating curve of 0.72, 0.78, and 0.77, respectively). Ranking patients by the EuroSCORE and dividing the cohort into 3 roughly equal risk groups yielded an ascending risk for infection of 0.7%, 3.0%, and 7.2%. The preoperative and intraoperative Society of Thoracic Surgeons risk scores showed good discrimination for surgical site infection (area under the receiver operating curve of 0.72 and 0.76, respectively) and excellent discrimination for early and late mortality (area under the receiver operating curve of >0.80). Risk grouping based on the Society of Thoracic Surgeons score yielded an ascending risk for infection of 0.7%, 3.6%, and 6.4%.
CONCLUSIONS: The EuroSCORE and the Society of Thoracic Surgeons risk score can be used for joint risk stratification for surgical site infection and mortality. Both scores performed better than the National Nosocomial Infections Surveillance risk index.
This article has been cited by other articles:
![]() |
T. C. Berg, K. E. Kjorstad, P. E. Akselsen, B. E. Seim, H. L. Lower, M. N. Stenvik, N. K. Sorknes, and H.-M. Eriksen National surveillance of surgical site infections after coronary artery bypass grafting in Norway: incidence and risk factors Eur J Cardiothorac Surg, December 1, 2011; 40(6): 1291 - 1297. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mannien, J. C. Wille, J. J. Kloek, and B. H. B. van Benthem Surveillance and epidemiology of surgical site infections after cardiothoracic surgery in The Netherlands, 2002-2007 J. Thorac. Cardiovasc. Surg., April 1, 2011; 141(4): 899 - 904. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ariyaratnam, M. Bland, and M. Loubani Risk factors and mortality associated with deep sternal wound infections following coronary bypass surgery with or without concomitant procedures in a UK population: a basis for a new risk model? Interact CardioVasc Thorac Surg, November 1, 2010; 11(5): 543 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Wilson Further reading OSH Cardiac Anaesthesia, January 1, 2010; 1(1): med-9780199209101-div1-90 - med-9780199209101-div1-90. [Full Text] |
||||
![]() |
I. S. Modrau, T. Ejlertsen, and B. S. Rasmussen Emerging Role of Candida in Deep Sternal Wound Infection Ann. Thorac. Surg., December 1, 2009; 88(6): 1905 - 1909. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Z. Atkins, M. K. Wooten, J. Kistler, K. Hurley, G. C. Hughes, and W. G. Wolfe Does Negative Pressure Wound Therapy Have a Role in Preventing Poststernotomy Wound Complications? Surgical Innovation, June 1, 2009; 16(2): 140 - 146. [Abstract] [PDF] |
||||
![]() |
M. Hartrumpf, T. Claus, M. Erb, and J. M. Albes Surgeon performance index: tool for assessment of individual surgical quality in total quality management Eur J Cardiothorac Surg, May 1, 2009; 35(5): 751 - 758. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. M. Nashef Predicting morbidity after coronary surgery Eur J Cardiothorac Surg, May 1, 2009; 35(5): 760 - 768. [Full Text] [PDF] |
||||
![]() |
J. Nakano, H. Okabayashi, M. Hanyu, Y. Soga, T. Nomoto, Y. Arai, T. Matsuo, M. Kai, and M. Kawatou Risk factors for wound infection after off-pump coronary artery bypass grafting: Should bilateral internal thoracic arteries be harvested in patients with diabetes? J. Thorac. Cardiovasc. Surg., March 1, 2008; 135(3): 540 - 545. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |